A Safety and Immunogenicity Study of Intranasal Sendai Virus Vectored Respiratory Syncytial Virus (SeVRSV) Vaccine in Healthy Adults
Clinical trial NCT03473002 · COMPLETED
Trial details
- NCT number
- NCT03473002
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-16
- Primary completion
- 2019-02-14
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.